-
Mashup Score: 21
Original Article from The New England Journal of Medicine — Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Source: New England Journal of MedicineCategories: Latest Headlines, RheumatologyTweet
Original Article from The New England Journal of Medicine — Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
RT @Nephro_Sparks: Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis #BLISSLN https://t.co/PMq9lZV1Et